This invention relates to medical implants for improving or modifying the performance of tissue structures in a patient's body such as a sphincter, a tubular conduit, or an organ. An illustrative use of the invention is improving the performance of a patient's lower esophageal sphincter (“LES”) as a treatment for gastro-esophageal reflux disorder or disease (“GERD”). However, this is only an example of how the invention may be used, and many other uses will be readily apparent to those skilled in the art. To list just a few further examples, the invention may be applied to other sphincters in the body such as sphincters in the urinary tract and elsewhere in the digestive tract. The apparatus of the invention may be used around the stomach as part of a treatment for obesity.
A common cause of GERD is inadequate functioning of the LES. The LES (and perhaps some associated tissue structures) normally keeps the lower part of the esophagus closed in order to prevent stomach contents from entering the esophagus. The LES opens during swallowing to allow whatever is being swallowed to pass from the esophagus into the stomach. The LES also opens to allow excess pressure in the stomach to escape via the esophagus. However, normal stomach pressure is substantially resisted by a normally functioning LES to keep the contents of the stomach from entering the esophagus. In a patient with GERD the cause is frequently an LES that has lost its ability (strength or “tone”) to resist normal stomach pressure and prevent stomach contents from coming back into the esophagus. This can cause discomfort (“heartburn”), and if left untreated, can cause damage to the esophagus that can lead to very serious adverse consequences for the patient.
It has been proposed to implant magnets in a GERD patient to improve the strength or tone of the patient's LES. For example, two magnets may be implanted in the esophagus on respective opposite sides of the esophageal lumen at or near the LES. Magnetic attraction between the magnets helps to hold the esophagus closed (except during swallowing or excess stomach pressure venting) and thereby reduces or eliminates the reflux of GERD. In following this approach, it would be desirable to avoid subjecting tissue to long-term, direct pressure from the magnets, such as when tissue between two mutually attracting magnets or magnetic structures is the only thing keeping the magnets or magnetic structures apart. Such pressure can interfere with blood flow to the tissue between the magnets or magnetic structures, which can be unhealthy for that tissue. For example, tissue death (necrosis) can result.
In accordance with the invention, a medical implant includes plural bodies, adjacent ones of which are resiliently attracted to one another (e.g., by magnetism, spring force, or the like). The bodies can be disposed in an array (e.g., an annular array) around a body tissue structure to be treated. The structure of the implant maintains an open area inside the array of at least a predetermined non-zero minimum size. Tissue passing through that area may be subjected to some residual pressure, e.g., of the kind and in an amount that improves the tone of a sphincter that is part of that tissue. But no part of the tissue is exposed to pressure of the kind that would be unhealthy for the tissue. If a normal body function (e.g., swallowing) causes the tissue structure passing through the array of bodies that make up the implant or prosthesis to need to expand, those bodies can move resiliently apart to allow such enlargement of the tissue structure. Thereafter, the bodies of the prosthesis move resiliently back toward one another again to help the tissue structure contract to its first-mentioned condition. However, this contraction of the prosthesis is limited by the prosthesis itself to always leave open at least the above-mentioned non-zero minimum area bounded by the prosthesis. The contracting prosthesis may not always reach the above-mentioned limit, if the prosthesis is sized or designed to apply some residual pressure to the tissue. But if that is the case, the residual pressure is small enough (e.g., it is the result of a relatively small force distributed over a relatively large area of tissue) so that it is not a problem for the tissue even if applied long-term.
Other aspects of the invention relate to methods for implanting a prosthesis in a patient in accordance with the invention. For example, an implant in accordance with the invention may be introduced into the patient in a substantially linear array. The array may be wrapped around the outside of the target body tissue structure. Opposite ends of the array may be joined to one another to form a closed loop around the target body tissue structure. These steps may be performed in any of a number of ways. For example, the implanting may be done surgically. As another example, the implanting may be done laparoscopically. As still another example, the prosthesis may be delivered into the patient via a body conduit of the patient, may then exit from that conduit at a location interior to the patient, and may then be implanted at the intended site using instrumentation that accompanies or follows the prosthesis into the patient via the conduit and out of that conduit at the interior location. As a specific example of the last-mentioned possibility, the prosthesis may be delivered into the patient in a linear condition via the patient's mouth and esophagus and into the stomach. The prosthesis may then exit through a temporary aperture in the side wall of the stomach and thereby enter the extra-luminal space. The prosthesis may then be secured around the external esophagus or upper stomach.
Further features of the invention, its nature and various advantages will be more apparent from the accompanying drawings and the following detailed description of the preferred embodiments.
As shown in
Each bead 20 in apparatus 10 is resiliently attracted to the adjacent beads in the string or loop. This resilient attraction may be provided by means such as magnetic force, spring force, or the like. Use of magnetic force will be described first. Other examples will be described later.
The hollow interior of each post 62 is large enough to easily and loosely accommodate end portions of two links 30 (or end portions of one link 30 and one link eyelet 40). (Because for this purpose link eyelets 40 are substantially similar to links 30, it will not be necessary to separately mention eyelets 40 again in this immediate discussion. It will be understood that they are subsumed in the discussion of links 30.) In each bead 20 one of the associated links 30 extends out of an aperture in the bottom of cup 60. This aperture is large enough to allow the main length of the link 30 to pass freely through the aperture, but it is not large enough to allow an enlarged stop 32 at the end of the link to pass through the aperture. The other link 30 associated with each bead 20 extends out of an aperture in the center of a washer-like cap 72 that is used to substantially close an aperture in the bottom of cup 70 and the otherwise open end of the hollow in post 62. Again, the aperture in cap 72 is large enough to allow the main length of the associated link 30 to pass freely through, but it is not large enough to allow the enlarged stop 32 at the end of the link to pass.
The various components of apparatus 10 can be assembled (during manufacture) as follows. Each link 30 can be initially provided with only one enlarged end stop 32. The other end of a link 30 can be passed successively through the aperture in the bottom of a cup 60 (not yet attached to a cup 70) and the aperture in a washer-like cap 72 (also not yet attached to a cup 70). An enlarged end stop 32 can be formed on the other end of the link 30. Magnets 80 can be placed in the cup 60. A cup 70 can be attached to the cup 60. A washer-like cap 72 can be attached to the cup 70.
Magnets 80 do not need to be biocompatible because the magnets can be completely sealed inside beads 20. The parts of apparatus 10 that will be exposed to a patient's body are preferably biocompatible. These components are cups 60 and 70 (including posts 62), washer-like caps 72, and links 30/40. An example of a biocompatible material that is suitable for these components is titanium, but many other suitable metallic and non-metallic materials are known to those skilled in art and can be used if and as desired. Assuming that one or more metals are used for components 30, 40, 60, 62, 70, and 72, enlarged end stops 32 may be formed as weld balls, annular hermetic welds may be formed between the abutting lips of cups 60 and 70, a similar annular hermetic weld may be formed between mating components 62 and 70, and spot welds may be used to secure washer-like caps 72 to the associated cups 70. Hermetic sealing of this last connection is not required because of the hermetic sealing between components 62 and 70. Alternatively, the mating between components 62 and 70 could be left unsealed, and a seal weld could be used between component 72, on the one hand, and components 62 and 70, on the other hand.
Note that the ends of each cylindrical bead 20 are preferably approximately spherical. Note also that links 30 may be somewhat bent laterally along their lengths. Features such as these help the structure form a closed loop that can resiliently enlarge and contract without mechanical interference (other than the intended ultimate limits on both enlargement and contraction as will now be described).
As has been mentioned, the magnets 80 in beads 20 resiliently attract adjacent beads into contact with one another as shown in
At all times that apparatus 10 is annularly enlarged to any degree, it is resiliently urged to return to its fully, annularly contracted condition by the magnetic attraction between beads 20. (Note that apparatus 10 has its lowest force urging contraction when beads 20 are at maximum separation from one another (e.g., as shown in
Certain aspects of the behavior of apparatus 10 are illustrated by
If, beyond the enlargement of apparatus 10 that has occurred when point B is reached, still more enlargement is needed, the force required to initiate such further enlargement returns to approximately the starting force as shown at point C. If at least such further enlargement force is present, two more of beads 20 will begin to separate to provide a further annular enlargement of apparatus 10.
The above-described process of beads 20 separating from one another one after another will continue, following the force and displacement diagram shown in
Turning now to more detail regarding how apparatus of the type shown and described above may be used as a medical implant in accordance with the invention, an illustrative use is as a treatment for gastro-esophageal reflux disorder or disease (“GERD”). In such a condition, the body structures that normally function to keep the lower part of the esophagus (near the stomach) closed, except when swallowing or when excessive pressure in the stomach needs to be relieved via the esophagus, is no longer functioning properly or adequately. This structure includes the lower esophageal sphincter (“LES”), possibly in cooperation with other tissue structures where the esophagus passes through the diaphragm (see
Apparatus 10 can be implanted as shown, for example, in
Any of several techniques can be used for introducing the implant 10 into the patient. For example, this may be done using open or relatively open surgery. As another example, the implant may be introduced into the patient using less invasive procedures such as laparoscopy and laparoscopic instruments. As still another example, the implant may be introduced trans-gastrically. In this technique the implant is introduced trans-orally into the esophagus, passed down the esophagus, and into the stomach. A dilator device is used to penetrate the wall of the stomach sufficient in size to allow the implant to be passed through this dilator into the space outside the stomach. The device, using instruments such as a stylet, can then be threaded around the lower esophagus. The implant can be connected into a closed loop with a suture, a clip, or stronger magnet beads located at each end. The implant may be modified to use an over-the-wire technique for this delivery method. In this case, a guide wire is placed around the distal esophagus and the implant is threaded over this wire once the wire is in position. The wire can then be removed.
It may be desirable to first measure or “size” the outer circumference of the esophagus where apparatus 10 is to be implanted. This may be done using one or more sizing instruments. When the desired implant size has been determined, an implant of that size may be implanted. Implants having different sizes may be provided by, for example, producing implants with different numbers of a given size bead 20, or by using beads 20 of different sizes to make implants of different sizes.
The implant may be medicated for any of several purposes. For example, such medication may include an antibiotic to combat infection, and/or the medication may include a steroid to promote appropriate healing.
With regard to the annular size of the prosthesis, it is currently thought desirable in the treatment of GERD, for example, to slightly “under-size” apparatus 10 for the outside of the esophageal tissue structure to which the apparatus will be applied. This means selecting a size of prosthesis such that when the implant is in place in the patient, there is at least some space in the annular or circumferential direction between two (preferably only two) of beads 20. (See
Continuing with the discussion of the example of applying apparatus 10 to a patient's esophagus, when the esophagus should be closed, the implant helps to keep it closed. However, when the patient swallows (e.g., a bolus of food), the implant annularly enlarges to the necessary extent to allow what has been swallowed down into the stomach. This may involve any number of beads 20 moving away from the adjacent bead(s). After any bolus has passed the plane of the implant, the implant resiliently returns to its initial, more annularly contracted condition. The same sequence of operations occur when excessive pressure in the stomach must be relieved through the esophagus. The implant annularly enlarges to vent the stomach, and then resiliently annularly contracts to return to its initial condition. The force exerted on the esophagus by the implant is preferably always large enough to help prevent reflux, but it is not so large as to impede swallowing or necessary venting of the stomach via the esophagus.
Over time, implanted apparatus 10 may become overgrown with tissue. However, this will not interfere with operation of the implant as described above. Tissue over-growth as described in this paragraph may make it possible to form the links 30 of the prosthesis from an absorbable (e.g., suture) material such as polyglycolic acid and/or polylactic acid. In embodiments of this type the links would degrade and disappear over time. Once the implant is integrated to the external esophagus and a fibrous tissue cap has conformed to at least part of the beads, the function of the links between the beads may not be necessary.
From the condition shown in
Although
It will be noted that spring embodiments (e.g., as in
If desired, any of the above-described embodiments (including the magnetic embodiments) can be augmented to produce substantially equal spacing between adjacent beads at all times.
Assuming that
Another illustrative embodiment of the invention is shown in
The arc length of each structure 520 is preferably sufficient that the ends of the one structure can contact the ends of the other structure beyond esophagus 50 (i.e., with no tissue of the esophagus between the contacting ends of the structures 520) as shown in
Each of structures 520 includes one or more magnets 580 for magnetically attracting the other structure 520, e.g., across the esophagus. This magnetic attraction is strong enough to hold structures 520 together as shown in
Like the earlier-described embodiments, embodiments of the type shown in
If desired, structures 520 like those shown in
When esophagus 50 opens as shown in
The length of belt 620 between the closed magnet pairs (as in
When esophagus 50 is closed as shown in
Such parameters as the number of beads 720, their shape (e.g., arched), etc., help ensure that when esophagus 50 is closed (
It will be understood that the foregoing is only illustrative of the principles of the invention, and that various modifications can be made by those skilled in the art without departing from the scope of the invention. For example, although application of the disclosed apparatus to a patient's esophagus in order to treat GERD has been given the most detailed attention herein, it will be understood that the invention has many other applications. For example, apparatus in accordance with the invention can be used around other body conduits, chambers, and/or sphincters in a patient's body. Just a few specific examples include use in treating urinary incontinence, anal incontinence, stomach size reduction, or as a completely artificial sphincter in the event that a natural sphincter has been removed or has wholly or largely ceased to function. Any of the structures shown and/or described herein as loops may be initially provided as open structures that are only formed into closed loops after placement around the target tissue structure. This principle is shown and described in detail in connection with embodiments like those illustrated by
This application is a continuation of U.S. patent application Ser. No. 16/204,043, entitled “Methods and Apparatus for Treating Body Tissue Sphincters and the Like,” filed Nov. 29, 2018, issued as U.S. Pat. No. 10,874,400 on Dec. 29, 2020, which is a continuation of U.S. patent application Ser. No. 14/445,723, entitled “Methods and Apparatus for Treating Body Tissue Sphincters and the Like,” filed Jul. 29, 2014, issued as U.S. Pat. No. 10,398,440 on Sep. 3, 2019, which is a divisional of U.S. patent application Ser. No. 13/403,441, entitled “Methods and Apparatus for Treating Body Tissue Sphincters and the Like,” filed Feb. 23, 2012, now abandoned, which is a divisional of U.S. patent application Ser. No. 12/610,633, entitled “Methods and Apparatus for Treating Body Tissue Sphincters and the Like, filed Nov. 2, 2009, issued as U.S. Pat. No. 8,187,164 on May 29, 2012, which is a continuation of Ser. No. 11/147,801, entitled “Methods and Apparatus for Treating Body Tissue Sphincters and the Like, filed Jun. 7, 2005, issued as U.S. Pat. No. 7,695,427 on Apr. 13, 2010, which claims the benefit of U.S. provisional patent applications 60/599,333, filed Aug. 5, 2004; 60/614,835, filed Sep. 30, 2004; and 60/653,966, filed Feb. 17, 2005.
Number | Name | Date | Kind |
---|---|---|---|
281371 | Keller | Jul 1883 | A |
3495620 | Bazell et al. | Feb 1970 | A |
3642004 | Osthagen et al. | Feb 1972 | A |
3750194 | Summers | Aug 1973 | A |
3798729 | Tanaka et al. | Mar 1974 | A |
3810259 | Summers et al. | May 1974 | A |
3812841 | Isaacson et al. | May 1974 | A |
3863622 | Buuck et al. | Feb 1975 | A |
3875928 | Angelchik | Apr 1975 | A |
3926175 | Allen et al. | Dec 1975 | A |
3939821 | Roth | Feb 1976 | A |
3952726 | Hennig et al. | Apr 1976 | A |
3991743 | Bucalo et al. | Nov 1976 | A |
4024855 | Bucalo et al. | May 1977 | A |
4053952 | Goldstein et al. | Oct 1977 | A |
4154226 | Hennig et al. | May 1979 | A |
4197840 | Beck et al. | Apr 1980 | A |
4209010 | Ward et al. | Jun 1980 | A |
4258705 | Sorensen et al. | Mar 1981 | A |
4271827 | Angelchik et al. | Jun 1981 | A |
D271478 | Kelman | Nov 1983 | S |
4412530 | Burton et al. | Nov 1983 | A |
4595390 | Hakim et al. | Jun 1986 | A |
4652257 | Chang et al. | Mar 1987 | A |
4773393 | Haber et al. | Sep 1988 | A |
4786276 | Haber et al. | Nov 1988 | A |
4832680 | Haber et al. | May 1989 | A |
4865588 | Flinchbaugh et al. | Sep 1989 | A |
4969474 | Schwarz et al. | Nov 1990 | A |
4994019 | Fernandez et al. | Feb 1991 | A |
5004454 | Beyar et al. | Apr 1991 | A |
5007940 | Berg et al. | Apr 1991 | A |
5041092 | Barwick et al. | Aug 1991 | A |
5088979 | Filipi et al. | Feb 1992 | A |
5140999 | Ardito et al. | Aug 1992 | A |
5160338 | Vincent et al. | Nov 1992 | A |
5176618 | Freedman et al. | Jan 1993 | A |
5234447 | Kaster et al. | Aug 1993 | A |
5234448 | Wholey et al. | Aug 1993 | A |
5236410 | Granov et al. | Aug 1993 | A |
5254126 | Filipi et al. | Oct 1993 | A |
5336263 | Ersek et al. | Aug 1994 | A |
5366506 | Davis et al. | Nov 1994 | A |
5387235 | Chuter et al. | Feb 1995 | A |
5397355 | Marin et al. | Mar 1995 | A |
5403326 | Harrison et al. | Apr 1995 | A |
5411552 | Andersen et al. | May 1995 | A |
5451406 | Lawin et al. | Sep 1995 | A |
5509888 | Miller et al. | Apr 1996 | A |
5562598 | Whalen et al. | Oct 1996 | A |
5593443 | Carter et al. | Jan 1997 | A |
5655546 | Halpern et al. | Aug 1997 | A |
5695504 | Gifford, III et al. | Dec 1997 | A |
5713877 | Davis et al. | Feb 1998 | A |
5725554 | Simon et al. | Mar 1998 | A |
5755658 | Wallace et al. | May 1998 | A |
5762599 | Sohn et al. | Jun 1998 | A |
5827321 | Roubin et al. | Oct 1998 | A |
5843164 | Frantzen et al. | Dec 1998 | A |
5861036 | Godin et al. | Jan 1999 | A |
5876448 | Thompson et al. | Mar 1999 | A |
5887594 | LoCicero | Mar 1999 | A |
5896756 | Watkins et al. | Apr 1999 | A |
5919233 | Knopf et al. | Jul 1999 | A |
5954506 | Tanaka | Sep 1999 | A |
5957949 | Leonhardt et al. | Sep 1999 | A |
5997467 | Connolly et al. | Dec 1999 | A |
6015431 | Thornton et al. | Jan 2000 | A |
6019789 | Dinh et al. | Feb 2000 | A |
6050982 | Wheeler et al. | Apr 2000 | A |
6056744 | Edwards et al. | May 2000 | A |
6073052 | Zelickson et al. | Jun 2000 | A |
6074341 | Anderson et al. | Jun 2000 | A |
6106548 | Roubin et al. | Aug 2000 | A |
6136006 | Johnson et al. | Oct 2000 | A |
6146416 | Andersen et al. | Nov 2000 | A |
6168621 | Vrba et al. | Jan 2001 | B1 |
6171231 | Connolly et al. | Jan 2001 | B1 |
6173715 | Sinanan et al. | Jan 2001 | B1 |
6190406 | Duerig et al. | Feb 2001 | B1 |
6203569 | Wijay et al. | Mar 2001 | B1 |
6231561 | Frazier et al. | May 2001 | B1 |
6251064 | Silverman et al. | Jun 2001 | B1 |
6254642 | Taylor et al. | Jul 2001 | B1 |
6264687 | Tomonto et al. | Jul 2001 | B1 |
6296607 | Milbocker et al. | Oct 2001 | B1 |
6302917 | Dua et al. | Oct 2001 | B1 |
6348033 | Catlett | Feb 2002 | B1 |
6409656 | Sangouard et al. | Jun 2002 | B1 |
6409723 | Edwards | Jun 2002 | B1 |
6419701 | Cook et al. | Jul 2002 | B1 |
6432038 | Bakane et al. | Aug 2002 | B1 |
6432040 | Meah | Aug 2002 | B1 |
6447533 | Adams | Sep 2002 | B1 |
6451048 | Berg et al. | Sep 2002 | B1 |
6460262 | Cabak et al. | Oct 2002 | B1 |
6464628 | Forsell et al. | Oct 2002 | B1 |
6475236 | Roubin et al. | Nov 2002 | B1 |
6497647 | Tucker | Dec 2002 | B1 |
6511491 | Grudem et al. | Jan 2003 | B2 |
6530934 | Jacobsen et al. | Mar 2003 | B1 |
6544291 | Taylor et al. | Apr 2003 | B2 |
6547776 | Gaiser et al. | Apr 2003 | B1 |
6551328 | Korlenbach | Apr 2003 | B2 |
6558429 | Taylor et al. | May 2003 | B2 |
6572605 | Humes et al. | Jun 2003 | B1 |
6592596 | Geitz | Jul 2003 | B1 |
6595909 | Silverman et al. | Jul 2003 | B2 |
6596004 | Regnault et al. | Jul 2003 | B1 |
6604529 | Kim | Aug 2003 | B2 |
6609522 | Cheng et al. | Aug 2003 | B2 |
6663639 | Laufer et al. | Dec 2003 | B1 |
6695878 | McGuckin et al. | Feb 2004 | B2 |
6730014 | Wilk et al. | May 2004 | B2 |
6736828 | Adams et al. | May 2004 | B1 |
6764518 | Godin et al. | Jul 2004 | B2 |
6776789 | Bryant et al. | Aug 2004 | B2 |
6830588 | Furukawa et al. | Dec 2004 | B2 |
6835200 | Laufer et al. | Dec 2004 | B2 |
D506943 | Erickson | Jul 2005 | S |
6960221 | Ho et al. | Nov 2005 | B2 |
6960233 | Berg et al. | Nov 2005 | B1 |
7025791 | Levine et al. | Apr 2006 | B2 |
7060080 | Bachmann et al. | Jun 2006 | B2 |
7087088 | Berg et al. | Aug 2006 | B2 |
7115879 | Leach et al. | Oct 2006 | B2 |
7238191 | Bachmann | Jul 2007 | B2 |
7288101 | Deem et al. | Oct 2007 | B2 |
7328707 | Durgin et al. | Feb 2008 | B2 |
7331969 | Inganas et al. | Feb 2008 | B1 |
7400926 | Forsell et al. | Jul 2008 | B2 |
7445010 | Kugler et al. | Nov 2008 | B2 |
7458930 | Meretei et al. | Dec 2008 | B2 |
7468060 | Utley et al. | Dec 2008 | B2 |
7488336 | Benchetrit et al. | Feb 2009 | B2 |
7497822 | Kugler et al. | Mar 2009 | B1 |
7566297 | Banik et al. | Jul 2009 | B2 |
7662087 | Bailly et al. | Feb 2010 | B2 |
7695427 | Kugler et al. | Apr 2010 | B2 |
7775966 | Dlugos et al. | Aug 2010 | B2 |
7775967 | Gertner et al. | Aug 2010 | B2 |
7811298 | Birk et al. | Oct 2010 | B2 |
7811299 | Bachmann et al. | Oct 2010 | B2 |
7879068 | Dlugos et al. | Feb 2011 | B2 |
7901418 | Danitz et al. | Mar 2011 | B2 |
8187164 | Kugler et al. | May 2012 | B2 |
10398440 | Kugler et al. | Sep 2019 | B2 |
10874400 | Kugler et al. | Dec 2020 | B2 |
20010020189 | Taylor | Sep 2001 | A1 |
20020078967 | Sixto et al. | Jun 2002 | A1 |
20020082621 | Schurr et al. | Jun 2002 | A1 |
20020198548 | Robert | Dec 2002 | A1 |
20030018377 | Berg et al. | Jan 2003 | A1 |
20030153806 | Miller | Aug 2003 | A1 |
20030199987 | Berg et al. | Oct 2003 | A1 |
20030212419 | West | Nov 2003 | A1 |
20030220660 | Kortenbach et al. | Nov 2003 | A1 |
20040006351 | Gannoe et al. | Jan 2004 | A1 |
20040034357 | Beane et al. | Feb 2004 | A1 |
20040044364 | DeVries et al. | Mar 2004 | A1 |
20040082963 | Gannoe et al. | Apr 2004 | A1 |
20040092892 | Kagan | May 2004 | A1 |
20040107004 | Levine et al. | Jun 2004 | A1 |
20040143342 | Stack et al. | Jul 2004 | A1 |
20040254622 | Shadduck | Dec 2004 | A1 |
20040260317 | Bloom et al. | Dec 2004 | A1 |
20040260319 | Egle | Dec 2004 | A1 |
20040260393 | Randert et al. | Dec 2004 | A1 |
20050021061 | Dennis | Jan 2005 | A1 |
20050085829 | Kraemer et al. | Apr 2005 | A1 |
20050096750 | Kagan et al. | May 2005 | A1 |
20050120746 | Winston | Jun 2005 | A1 |
20050197715 | Kugler et al. | Sep 2005 | A1 |
20050251181 | Bachmann | Nov 2005 | A1 |
20050251182 | Bachmann | Nov 2005 | A1 |
20050283235 | Kugler et al. | Dec 2005 | A1 |
20060200179 | Barker et al. | Sep 2006 | A1 |
20060241748 | Lee et al. | Oct 2006 | A1 |
20060252982 | Hassler et al. | Nov 2006 | A1 |
20060252983 | Lembo et al. | Nov 2006 | A1 |
20060252984 | Rahdert et al. | Nov 2006 | A1 |
20060276684 | Speziali | Dec 2006 | A1 |
20060276812 | Hill et al. | Dec 2006 | A1 |
20070004963 | Benchetrit | Jan 2007 | A1 |
20070015954 | Dlugos | Jan 2007 | A1 |
20070016231 | Jambor et al. | Jan 2007 | A1 |
20070021761 | Phillips | Jan 2007 | A1 |
20070027356 | Ortiz | Feb 2007 | A1 |
20070027357 | Bertolero et al. | Feb 2007 | A1 |
20070043256 | Banik | Feb 2007 | A1 |
20070073099 | Forsell | Mar 2007 | A1 |
20070078296 | Sabri | Apr 2007 | A1 |
20070167672 | Dlugos et al. | Jul 2007 | A1 |
20070208360 | Demarais et al. | Sep 2007 | A1 |
20070213751 | Scirica et al. | Sep 2007 | A1 |
20070249894 | Nicholson | Oct 2007 | A1 |
20070250087 | Makower et al. | Oct 2007 | A1 |
20080027469 | Bachmann | Jan 2008 | A1 |
20080083413 | Forsell | Apr 2008 | A1 |
20080146869 | Chow et al. | Jun 2008 | A1 |
20080161875 | Stone | Jul 2008 | A1 |
20080177292 | Jacobs et al. | Jul 2008 | A1 |
20080183196 | Jarsaillon et al. | Jul 2008 | A1 |
20080287975 | Weaner et al. | Nov 2008 | A1 |
20090043356 | Longhini et al. | Feb 2009 | A1 |
20090054950 | Stephens | Feb 2009 | A1 |
20090062824 | Berg et al. | Mar 2009 | A1 |
20090062825 | Pool et al. | Mar 2009 | A1 |
20090062826 | Steffen | Mar 2009 | A1 |
20090082793 | Birk | Mar 2009 | A1 |
20090125102 | Cartledge et al. | May 2009 | A1 |
20090157107 | Kierath et al. | Jun 2009 | A1 |
20090171378 | Coe et al. | Jul 2009 | A1 |
20090198261 | Schweikert | Aug 2009 | A1 |
20090202387 | Dlugos et al. | Aug 2009 | A1 |
20090216255 | Coe et al. | Aug 2009 | A1 |
20090216256 | Nicholson | Aug 2009 | A1 |
20090228028 | Coe et al. | Sep 2009 | A1 |
20090240268 | Kassab et al. | Sep 2009 | A1 |
20090240269 | Denis | Sep 2009 | A1 |
20090306462 | Lechner | Dec 2009 | A1 |
20090306463 | Mouton et al. | Dec 2009 | A1 |
20100030014 | Ferrazzi | Feb 2010 | A1 |
20100099945 | Birk et al. | Apr 2010 | A1 |
20100114131 | Rotunda | May 2010 | A1 |
20100179376 | Kassab et al. | Jul 2010 | A1 |
20100185049 | Birk et al. | Jul 2010 | A1 |
20100191265 | Lau et al. | Jul 2010 | A1 |
20100217071 | Ricol | Aug 2010 | A1 |
20100280310 | Raven | Nov 2010 | A1 |
20100312046 | Lau et al. | Dec 2010 | A1 |
20100324359 | Birk | Dec 2010 | A1 |
20110034760 | Brynelsen et al. | Feb 2011 | A1 |
20110034761 | Ricol | Feb 2011 | A1 |
20110034762 | Paganon | Feb 2011 | A1 |
20110040141 | Bachmann et al. | Feb 2011 | A1 |
20110054248 | Birk et al. | Mar 2011 | A1 |
20110071341 | Dlugos et al. | Mar 2011 | A1 |
20110071557 | Dlugos et al. | Mar 2011 | A1 |
20110071558 | Dlugos et al. | Mar 2011 | A1 |
20110152608 | Bachmann et al. | Jun 2011 | A1 |
20110152901 | Woodruff et al. | Jun 2011 | A1 |
20120150214 | Kugler et al. | Jun 2012 | A1 |
Number | Date | Country |
---|---|---|
2480343 | Oct 2003 | CA |
3011742 | Oct 1981 | DE |
3011742 | Oct 1981 | DE |
0341039 | Nov 1989 | EP |
S53-107507 | Aug 1978 | JP |
S58-008323 | Jan 1983 | JP |
S59-069744 | Apr 1984 | JP |
H04-117905 | Oct 1992 | JP |
WO 9319702 | Oct 1993 | WO |
WO 9844965 | Oct 1998 | WO |
WO 0054835 | Sep 2000 | WO |
WO 0059398 | Oct 2000 | WO |
WO 0108717 | Feb 2001 | WO |
WO 0147431 | Jul 2001 | WO |
WO 02094132 | Nov 2002 | WO |
WO 04004544 | Jan 2004 | WO |
WO 2009005634 | Jan 2009 | WO |
Entry |
---|
“GI Endoscopy: Therapies for GERD,” Medtech Insight, Sep. 2001, p. 236. |
Alksne, J. et al., “Iron-acrylic compound for stereotaxic aneurysm thrombosis,” J. Neurosurg., vol. 47, pp. 137-141 (Aug. 1977). |
Branton, S.A. et al., “Surgical Treatment of Gastroesophageal Reflux Disease,” The Esophagus, Lippincott Williams & Wilkins, Castell, D.O. et al., Third Edition, 1999, pp. 511-525. |
Evangelisto, Mary, “How Do Some Spell Relief? S-u-r-g-e-r-y,” Today's Surgical Nurse, vol. 19, No. 1, 1997, pp. 22-28. |
Gruneburger, A.D. et al., “Entwicklung eines magnetischen Urethralverschlusses-eine tier-experimentelle Studie,” Zentralbl Gynakol, vol. 115, pp. 328-331 (1993). |
Gruneburger, A.D., “Entwicklung eines magnetischen Urethralverschlusses and erste klinische Erfahrungen,” Urologe A, vol. 26, pp. 106-111 (1987). |
Gruneburger, A.D., “Klinische Erfahrungen mit einem magnetischen Hamrohrenverschlu8,” Geburtsch. u. Frauenheilk., vol. 50, pp. 150-154 (1990). |
Gruneburger, A.D., “Modifikation der Anwendung der Magnetschale des Harnrohrenverschlusses bei Rezidiv-Inkontinenz,” Geburtsch. u. Frauenheilk., vol. 51, pp. 850-852 (1991). |
Kahrilas, P.J. et al., “Hiatus Hernia,” The Esophagus Lippincott Williams & Wilkins, Castell, D.O. et al., Third Edition, 1999, pp. 381-396. |
MUSC Digestive Disease Center, “Digestive Problems: Esophagus—GERD,” Oct. 13, 2003, accessed Mar. 3, 2004 at www.ddc.musc.edu/ddc_pub/digestiveProbs/diseases/esophagus/GERD.htm. |
MUSC Digestive Disease Center, “Patient Information: Laparoscopic Surgeries—Fundoplication,” Oct. 13, 2003, accessed Mar. 3, 2004 at www.ddc.musc.edu/ddc_pub/patientInfo/surgeries/laparoscopic/ fundoplication.htm. |
Sayre, J.T., et al., “Current Experiences with the Management of Paraesophageal Hernias,” Connecticut Medicine, vol. 44, No. 4, Apr. 1980, pp. 197-203. |
Shigley et al., Mechanical Engineering Design, Fifth Edition, 1989, McGraw-Hill, Inc., New York, pp. 58-60. |
European Examination Report dated Dec. 28, 2010 for Application No. EP 05775698.3, 4 pgs. |
European Communication, Intention to Grant, dated Dec. 5, 2014 for Application No. EP 05775698.3, 58 pgs. |
European Search Report and Written Opinion dated Mar. 7, 2012 for Application No. EP 11192074.0, 6 pgs. |
European Examination Report dated Jul. 21, 2015 for Application No. EP 11192074.0, 4 pgs. |
European Examination Report dated Nov. 30, 2017 for Application No. EP 11192074.0, 3 pgs. |
European Communication, Intention to Grant, dated May 3, 2018 for Application No. EP 11192074.0, 48 pgs. |
European Search Report and Written Opinion dated Mar. 7, 2012 for Application No. EP 11192082.3, 5 pgs. |
European Examination Report dated Jul. 21, 2015 for Application No. EP 11192082.3, 3 pgs. |
Extended European Search Report and Written Opinion dated Feb. 12, 2019 for Application No. EP 18190008.5, 6 pgs. |
International Search Report and Written Opinion dated Nov. 2, 2004 for Application No. PCT/US2004/002386, 15 pgs. |
International Search Report and Written Opinion dated Jul. 4, 2005 for Application No. PCT/US2005/005826, 12 pgs. |
International Search Report and Written Opinion dated Dec. 29, 2005 for Application No. PCT/US2005/026469, 11 pgs. |
Japanese Office Action, Notification of Reasons for Refusal, dated Mar. 23, 2011 for Application No. JP 2007-524843, 3 pgs. |
Japanese Office Action, Notification of Reasons for Refusal, dated Dec. 2, 2011 for Application No. JP 2007-524843, 2 pgs. |
Japanese Office Action, Decision to Grant a Patent, dated Mar. 2, 2012 for Application No. JP 2007-524843, 3 pgs. |
U.S. Appl. No. 10/732,693, filed Dec. 9, 2003, by Berg. |
U.S. Appl. No. 60/614,835, filed Sep. 30, 2004. |
U.S. Appl. No. 60/653,966, filed Feb. 17, 2005. |
Number | Date | Country | |
---|---|---|---|
20210128156 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
60653966 | Feb 2005 | US | |
60614835 | Sep 2004 | US | |
60599333 | Aug 2004 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13403441 | Feb 2012 | US |
Child | 14445723 | US | |
Parent | 12610633 | Nov 2009 | US |
Child | 13403441 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16204043 | Nov 2018 | US |
Child | 16953503 | US | |
Parent | 14445723 | Jul 2014 | US |
Child | 16204043 | US | |
Parent | 11147801 | Jun 2005 | US |
Child | 12610633 | US |